Showing 1 - 11 results of 11 for search 'Nobuyuki Yamamoto', query time: 0.03s
Refine Results
-
1
Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled... by Eriko Murakami, Hiroaki Akamatsu, Toshio Shimokawa, Kiyoko Wada, Nobuyuki Yamamoto
Published 2019-12-01Get full text
Article -
2
-
3
Comparison of the Immune Checkpoint Inhibitor‐Free Survival Between Patients Who Completed and Those Who Discontinued ICI for Non‐Small Cell Lung Cancer by Takahiro Nagai, Hiroaki Akamatsu, Eri Takase, Eriko Murakami, Takeya Sugimoto, Ryota Shibaki, Atsushi Hayata, Toshio Shimizu, Masanori Nakanishi, Yasuhiro Koh, Nobuyuki Yamamoto
Published 2025-06-01Get full text
Article -
4
A noncontact vital sign sensor demonstrating a strong correlation with an electrocardiogram electrode and a CO2 sensor by Tatsuya Nagano, Nobuyuki Yamamoto, Sae Shinomiya, Hiroshi Kato, Mariko Okamoto, Daisuke Hazama, Ryosuke Bo, Tomohiko Yamamura, Takumi Imai, Koji Fukuzawa, Takuya Funayama, Koji Kano, Naoko Katsurada
Published 2025-05-01Get full text
Article -
5
Chest Tube Drainage, Bone Radiotherapy, and Brain Radiotherapy in Advanced Lung Cancer: A Retrospective Analysis of Associated Factors and Survival by Shoko Sonobe Shimamura, Takehito Shukuya, Kazuhisa Takahashi, Yasushi Shintani, Ikuo Sekine, Koichi Takayama, Akira Inoue, Isamu Okamoto, Tomoya Kawaguchi, Nobuyuki Yamamoto, Etsuo Miyaoka, Ichiro Yoshino, Hiroshi Date
Published 2025-04-01Get full text
Article -
6
Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients. by Satomi Yagi, Yasuhiro Koh, Hiroaki Akamatsu, Kuninobu Kanai, Atsushi Hayata, Nahomi Tokudome, Keiichiro Akamatsu, Katsuya Endo, Seita Nakamura, Masayuki Higuchi, Hisashige Kanbara, Masanori Nakanishi, Hiroki Ueda, Nobuyuki Yamamoto
Published 2017-01-01Get full text
Article -
7
Importance of E/e’ and BNP for early detection of late cardiotoxicity in long-term follow-up of childhood hematologic cancer survivors: a retrospective cross-sectional study by Yuri Okazoe-Hirakawa, Kimikazu Yakushijin, Keiji Kurata, Sakuya Matsumoto, Hiroya Ichikawa, Rina Sakai, Taku Nose, Shiro Kimbara, Yoshiaki Nagatani, Taiji Koyama, Yumiko Inui, Yohei Funakoshi, Naomi Kiyota, Mitsuhiro Ito, Keiko Hatazawa, Hidekazu Tanaka, Nobuyuki Yamamoto, Hironobu Minami
Published 2025-06-01Get full text
Article -
8
Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer by Hirotaka Matsumoto, Hiroaki Akamatsu, Nobuyuki Yamamoto, Yuki Sato, Daichi Fujimoto, Yoshihiko Taniguchi, Motohiro Tamiya, Yasuhiro Koh, Junya Fukuoka, Hisashi Tanaka, Naoki Furuya, Ryota Shibaki, Tsukasa Nozawa, Akira Sano, Yuka Kitamura, Takashi Kijima, Toshihide Yokoyama, Satoru Miura, Akito Hata, Jun Sugisaka
Published 2024-02-01Get full text
Article -
9
Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L) by Nobuyuki Yamamoto, Ryoji Kato, Hidetoshi Hayashi, Yasutaka Chiba, Eriko Miyawaki, Junichi Shimizu, Tomohiro Ozaki, Daichi Fujimoto, Ryo Toyozawa, Atsushi Nakamura, Toshiyuki Kozuki, Kentaro Tanaka, Shunsuke Teraoka, Kazuhiro Usui, Kazumi Nishino, Osamu Hataji, Keiichi Ota, Noriyuki Ebi, Sho Saeki, Yuki Akazawa, Motoyasu Okuno, Kazuhiko Nakagawa
Published 2020-05-01Get full text
Article -
10
Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50% by Yoshihito Kogure, MD, PhD, Hiroya Hashimoto, PhD, Haruko Daga, MD, PhD, Yasushi Fukuda, MD, Akihiro Bessho, MD, PhD, Tadaaki Yamada, MD, PhD, Yukihiro Toi, MD, Tomoki Kimura, MD, PhD, Hiroshige Yoshioka, MD, PhD, Koichi Azuma, MD, PhD, Naoki Furuya, MD, PhD, Yasutaka Fukui, MD, PhD, Akiko M. Saito, MD, PhD, Nobuyuki Yamamoto, MD, PhD, Hideo Saka, MD, Masashi Kondo, MD, PhD
Published 2025-03-01Get full text
Article -
11
Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L by Hideyuki Harada, MD, PhD, Akito Hata, MD, Masahiro Konno, PhD, Nobuaki Mamesaya, MD, PhD, Kiyoshi Nakamatsu, MD, PhD, Koji Haratani, MD, PhD, Takaya Yamamoto, MD, PhD, Ryota Saito, MD, PhD, Hiroshi Mayahara, MD, PhD, Masaki Kokubo, MD, PhD, Yuki Sato, MD, Nobuki Imano, MD, PhD, Takeshi Masuda, PD, PhD, Haruyuki Fukuda, MD, PhD, Toshikatsu Sado, MD, PhD, Kenichi Yoshimura, PhD, Yasumasa Nishimura, MD, PhD, Kazuhiko Nakagawa, MD, PhD, Isamu Okamoto, MD, PhD, Nobuyuki Yamamoto, MD, PhD
Published 2025-06-01Get full text
Article